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A set of 10 4,7-dimethoxy-1,3-benzodioxole derivatives based on a lead compound previously discovered by our group, SY-1,
which was isolated from Antrodia camphorata, were evaluated for their in vitro inhibitory activity on human colorectal carcinoma
cells (COLO 205). Structure-activity relationship studies of the 10 compounds indicated the importance of the chain length of
the alkyl group at the 5-position, and the 2-propenyl substituent named “apiole” exhibited the most potent inhibitory activity.
In the present study, we demonstrate that the SY-1 analogue “apiole” decreased the proliferation of COLO 205 cells, but not that
of normal human colonic epithelial cells (FHC). The G0/G1 cell cycle arrest induced by apiole (75–225μM) was associated with
signiﬁcantly increased levels of p53, p21 and p27 and decreased levels of cyclin D1. Concerning COLO 205 cell apoptosis, apiole
(>150μM) treatment signiﬁcantly increased the levels of cleaved caspases 3, 8, 9 and bax/bcl-2 ratio and induced ladder formation
in DNA fragmentation assay and sub-G1 peak in ﬂow cytometry analysis. These ﬁndings suggest that apiole can suppress COLO
205 cell growth; however, the detailed mechanisms of these processes require further investigation.
1.Introduction
The most prevalent form of cancer among Taiwanese people
is colorectal cancer, topping the list of the ﬁve most common
cancers in Taiwan according to a 2006 cancer report released
by the Department of Health. About 15.03 per 100000
individuals die per year of colorectal cancer, and the current
clinicaltherapiesarelimitedtosurgery,radiotherapy,general
chemotherapy and gene therapy [1–3]. There is clearly an
urgent need to identify new therapeutic agents for the
treatment of colon cancer.
Antrodia camphorata has been used in traditional Chi-
nese medicine to treat hypertension, pruritus, diarrhea and
liver cancer. Previously, we reported that a unique com-
pound, 4,7-dimethoxy-5-methyl-1,3-benzodioxole (SY-1),
isolated from A. camphorata extracts, was able to profoundly
decrease the proliferation of human COLO cancer cells
(COLO 205) through G0/G1 cell cycle arrest and the induc-
tion of apoptosis [4]. Although SY-1 caused a signiﬁcant
increase in p53 expression in COLO 205 cells, we decided to
evaluate the possibility of further modiﬁcations at position
5 of the SY-1 structure, with the goal of developing more
eﬃcient anti-cancer agents. The anti-tumor activities of
4,7-dimethoxy-1,3-benzodioxoles are largely unknown and
therefore we screened 10 5-substituted 4,7-dimethoxy-1,3-
benzodioxoles as model agents to investigate novel anti-
human colon cancer agents with increased potency. Thus,
a series of 4,7-dimethoxy-1,3-benzodioxole derivatives were
evaluated for their anti-proliferation activity.
Among those compounds, 4,7-dimethoxy-5-(2-propen-
1-yl)-1,3-benzodioxole, also named apiole, apiol or parsley
apiol, which is an essential oil component of the fruits of2 Evidence-Based Complementary and Alternative Medicine
Petroselinumcrisp[5],seedsofEnterolobiumcontortisiliquum
(leguminosae)[6], wild-growing Salvia aegyptiaca[7],leaves
of Cinnamomum verum Presl. [8] and leaves and fruits of
Caraway (Carum carvi L.)[ 9]a n dPituranthos chloranthus
ssp. [10], was evaluated. This compound shows potent
calcium channel blocking activity [5, 11], with a strong
depressing eﬀect on the force of contraction (IC50 = 30μM).
Essential oil from seeds of Enterolobium contortisiliquum
that contained apiole shows weak antimicrobial activity
against gram-positive bacteria (Bacillus subtilis, Bacillus
cereus, Staphylococcus aureus, Micrococcus luteus)[ 6]. This
report is the ﬁrst to demonstrate that apiole could have more
potent inhibitory eﬀects than SY-1 against COLO 205 and
could be developed into a potent anti-colon cancer drug.
2. Methods
2.1. Chemicals and Reagents. 5-Substituted 4,7-dimethoxy-
1,3-benzodioxoles (compounds 1–9) were purchased from
Aurora Fine Chemicals Ltd, Austria, and apiole was obtained
from the Uni-onward Company, Taiwan. The structures of
all compounds were identiﬁed by NMR spectroscopy.
2.2. Cell Culture. The COLO 205 (p53 wild-type) cell line
was isolated from human colon adenocarcinoma (CCL-
222; American Type Culture). The cell line was grown in
RPMI-1640 medium (Invitrogen, Carlsbad, CA) containing
10% fetal bovine serum (FBS) (Invitrogen Carlsbad, CA)
and 1% penicillin–streptomycin (Invitrogen, Carlsbad, CA).
FHC (CRL-1831; American Type Culture Collection) is a cell
line derived from long-term epithelial cell cultures of normal
humanfetalcolonicmucosa[12].Cultureswereincubatedin
a3 7 ◦C incubator with a humidiﬁed atmosphere of 5% CO2.
2.3. Cell Viability Assay. The anti-proliferative eﬀects of
the compounds on cultured cells were measured using the
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay. The cells were seeded at a density of 2 ×
104 cells per well in 24-well culture plates overnight and
then treated with various concentrations of the compounds.
After 24, 48 and 72 hours of incubation, 30μL of 2mgmL−1
MTT solution (in phosphate buﬀered saline (PBS), pH
7.4) was added to each well, and the plate was incubated
for another 3 hours. Following incubation, the culture
medium was removed from the wells by slow aspiration and
replaced with 200μlD M S O .T h ea b s o r b a n c eo fe a c hw e l l
wasmeasuredusinganenzyme-linkedimmunosorbentassay
(ELISA) reader at 550 nm.
2.4. Flow Cytometry Analysis. The COLO 205 cells were
harvested at various times after treatment with diﬀerent
concentrations of apiole with trypsin–EDTA, washed twice
with ﬁltered PBS and then ﬁxed in 70% ethanol at 4◦C
for >24 hours. Fixed cells were washed once with ﬁltered
PBS and treated with DNase-free RNase (2UmL−1)f o r3 0
min, followed by staining with propidium iodide reagent
(3.8mM sodium citrate, 0.1% Triton X-100 and 20μgmL −1
propidium iodide). The DNA content was measured by
ﬂow cytometry (Cytomics FC500, Beckman Coulter). The
percentageofcellsineachphaseofthecellcyclewasanalyzed
using software (Multicycle 32bit version, Beckman Coulter).
2.5. Immunoblotting Analysis. The COLO 205 cells were
treated with various concentrations of apiole for diﬀerent
durations, and the cell lysates produced in the lysis buﬀer
(20mM Tris–HCl, pH 7.4, 1% NP-40, 137mM NaCl, 50μM
EDTA, protease inhibitor cocktail and 1mM PMSF) were
used for immunoblotting [13]. Protein samples were ana-
lyzed by direct immunoblotting (100μg per lane). Immun-
odetection was carried out by probing with appropriate dilu-
tions of speciﬁc antibodies at 4◦C overnight. The primary
antibodies were diluted at 1:100 and 1:1000, including
anti-cyclin D1 and anti-p27 (Santa Cruz, Inc., CA, USA),
anti-actin (Chemicon Co., MA, USA), anti-cleaved caspase
3,8,9 (Cell Signaling Technology, Inc., MA, USA), anti-
p21 and anti-p53 (BD Bioscience, CA, USA), anti-bax and
anti-bcl-2 (Assay Designs, MI, USA). Secondary antibodies,
including peroxidase-conjugated goat anti-mouse or anti-
rabbit antibodies and alkaline phosphatase-conjugated goat
anti-mouseantibody(JacksonImmunoResearchLaboratory,
PA, USA), were incubated at room temperature for 1 hour at
a dilution of 1:5000. ECL detection reagent and BCIP/NBT
substrate solution (Perkin Elmer Co., MA, USA) were used
to visualize immunoreactive proteins on PVDF membranes
after transfer by Trans-Blot SD (Bio-Rad Co., CA, USA).
2.6.AnalysisofDNAFragmentation. ApoptosisinCOLO205
cells subjected to the various treatments was determined by
DNA fragmentation analysis [14] .T h eg e n o m i cD N Aw a s
extracted and electrophoresed in a 2% agarose gel. The DNA
was visualized by ethidium bromide staining.
2.7. Statistics. A l lv a l u e sa r ep r e s e n t e da sm e a n s± SE.
Signiﬁcant comparisons were subjected to Dunnett’s one-
way ANOVA. Signiﬁcance was deﬁned as P < .05.
3. Results
3.1. Cytotoxic Activity of 5-Substituted 4,7-Dimethoxy-1,3-
Benzodioxole Derivatives on Human Colon Cancer Cells.
Our previous studies showed that SY-1 induces cytotoxicity
in the human colorectal adenocarcinoma COLO 205 cell
line [4]. In the present study, anti-proliferation eﬀects of
10 SY-1 derivatives were examined using the MTT assay.
COLO 205 cells were treated with each compound (37.5–
225μM) for varying durations. Similar anti-proliferation
activitywasobservedintheCOLO205cellline(Figure 1(a)).
Interestingly, we found that 5-position functional groups
with aliphatic substituents (compounds 4, 5 and apiole)
had more potent anti-proliferative eﬀects than polar alkyl
functional groups (compounds 1–3). The IC50 values of
compounds 1, 2, 3, 4, 5 and 6 were measured to be 59.4,
152.3, 148.5, 72.1, 110.9 and 66.7μM, respectively. However,
bulkier substituents at the 5-position (such as compounds 7,
8 and 9) displayed very weak (>225μM) inhibitory activity
(Figure 1(a)).Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Cell growth inhibitory eﬀects of SY-1 derivative compounds in normal and malignant human cells. (a) Human colorectal
adenocarcinoma cells (COLO 205) were treated with SY-1 derivatives at varying doses and for diﬀerent durations. (b) FHC cells were treated
with apiole (37.5–225μM) for varying durations. An MTT assay was then performed to determine the cell viability. All of these experiments
were performed at least three times, and the results are presented as means ± SE.4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Dose-dependent eﬀects of apiole on G0/G1 phase arrest in COLO 205 cells. COLO 205 cells were treated with apiole (0, 37.5,
75, 150 and 225μM) in 0.05% DMSO and sampled by ﬂow cytometry and immunoblotting analysis 15 hours following treatment. (a) The
percentages of cells in the sub-G1, G0/G1, S and G2/M phases of the cell cycle were determined using Multicycle analysis software. Three
samples were analyzed in each group, and the values represent means ± SE. ∗P < .05 versus the control group. (b) Eﬀect of apiole on the
expression levels of cell cycle regulatory proteins. Protein extracts (100μg per lane) were separated by SDS-PAGE and probed with speciﬁc
antibodies. Membranes were also probed with an anti-β-actin antibody to correct for diﬀerences in protein loading.
The most potent compound among 10 4,7-dimethoxy-
1,3- benzodioxoles against COLO 205 was apiole, which
exhibited IC50 values that were signiﬁcantly <37.5μMa t4 8
hours and 72 hours (Figure 1(a)) .T h es i d ec h a i nd e r i v a t i v e s
were divided into 2-propenyl (apiole) and n-propyl groups
(compound 5), and the anti-proliferative activity of apiole
was found to be 3-fold higher than that of n-propyl in
COLO 205 cells. To test whether the suppression of COLO
205 cancer cell proliferation by SY-1 derivatives was cell-
type speciﬁc, normal human colonic epithelial (FHC) cells
were treated with apiole at varying doses and for diﬀerent
durations (Figure 1(b)). The cytotoxic activity of apiole was
not observed in the normal human cell line (Figure 1(b)).
Accordingly, apiole was selected as a more potent compound
to study the mechanism of its anti-proliferative activity
compared to the other SY-1 derivatives with structural mod-
iﬁcations at position 5 of 4,7-dimethoxy-1,3-benzodioxole.
3.2. Apiole Induces Cell Cycle Arrest in Human Colon Cancer
Cells. Figure 2 demonstrates the dose-dependent eﬀects of
apiole on G0/G1 arrest. According to our previous studies
[4, 15], the greatest diﬀerence between COLO 205 cells in the
G0/G1 cell population of the treatment and control groups
was recorded 15 hours after replacement with complete
medium. Accordingly, this time point (15h) was selected to
study the dose-dependent eﬀects of apiole on the induction
of cell cycle arrest, as determined by ﬂow cytometry analysis.
As shown in Figure 2(a), signiﬁcant G0/G1 arrest was
inducedinCOLO205cellstreatedwithapiole(>75μM),and
this eﬀect was dose dependent. Our previous study showed
that cyclin-dependent kinase inhibitors (CDKi), such as
p21 and p27, are upregulated in human colon cancer cells
arrested in G0/G1 by treatment with anti-cancer agents
[4, 15, 16]. In the present study, COLO 205 cells exposed to
apiole (<150μM) displayed induction of p21, p27 and p53
and decreased expression of cyclin D1 (Figure 2(b)).
3.3. Apiole Activates Caspases for Apoptosis in Human Colon
CancerCells. Tofurtherdemonstratethatapoptosiscouldbe
detected in human COLO 205 cells, the cells were exposed
to apiole for 36–48 hours. Figures 3(a)–3(d) demonstrates
the time- and dose-dependent eﬀects of apiole on cell cycle
regulation. A higher dose (150, 225μM) of apiole at 36 and
48hourssigniﬁcantlyincreasedthepopulationofthesub-G1
p e a k ,a sd e t e c t e db yﬂ o wc y t o m e t r ya n a l y s i s .P r e v i o u sw o r k
has demonstrated that the occurrence of apoptosis requires
the activation of caspases [17, 18]; therefore, we investigated
the involvement of caspase activation and bax/bcl-2 ratio in
COLO 205 cells following apiole treatment by immunoblot-
ting analysis. The results show that apiole (150 or 225μM
for 36h) induced apoptosis in COLO 205 cells with the
increase of bax/bcl-2 ratio and cleavage of caspases 3, 8 and 9
(Figure 3(e)).Next,weinvestigatedapiole-inducedapoptosis
on COLO 205 cells by DNA fragmentation analysis. DNA
fragmentationwasonlyobservedintheapiole-treatedCOLO
205 cells after 36 hours (>75μM). Indeed, DNA fragmen-
tation was induced by a higher dose of apiole (150μM) asEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Time- and dose-dependent eﬀects of apiole on the apoptosis of COLO 205 cells. Synchronized COLO 205 cells were sampled
immediately at 15, 36 and 48 hours after 10% FCS treatment. Cells in the (a) control, (b) 75μM, (c) 150μM and (d) 225μM apiole-treated
groups were then harvested for ﬂow cytometry analysis. The percentages of cells in the sub-G1, G0/G1, S and G2/M phases of the cell cycle
were determined using the well-known Multicycle analysis software. Three samples were analyzed in each group, and the values represent
means ± SE. ∗P < .05 versus the control group. (e) Eﬀect of apiole treatment on apoptosis regulatory proteins in human COLO 205 cells.
The COLO 205 cells were treated with the same regimens as described in ((a–d)). Protein lysates were separated by SDS-PAGE and probed
with speciﬁc antibodies. Membranes were also probed with an anti-β-actin antibody to correct for diﬀerences in protein loading.6 Evidence-Based Complementary and Alternative Medicine
Table 1: Structures and IC50 values of 5-substituted 4,7-dimethoxy-1, 3-benzodioxole derivatives for the inhibition of COLO 205 cells at 48
hours.
OCH3
R
OCH3
O
O
Compound R IC50 (μM)
SY-1
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Apiole
–CH3
–CN
–COOH
–CH2CH2OH
–COOCH3
–(CH2)2CH3
–CH2CH(OH)CH2CN
–CH2CH = CH2
ON
F
S
N
H O N F
N
N
H
O
N O
> 375
59.4
152.3
148.5
72.1
110.9
66.7
> 225
> 225
> 225
> 37.5
M0 3 7 .5 75 150 225 (μM)
COLO 205
500bp
400bp
300bp
200bp
100bp
Figure 4: Dose-dependent apiole-induced DNA fragmentation in
human colon cancer. COLO 205 cells were treated with apiole at
the indicated doses. Induction of apoptosis in all cells was shown by
DNA fragmentation using electrophoresis of genomic DNA. DNA
fragmentation was examined 36 hours after drug treatment.
shown in Figure 4. These results suggest that apiole induced
apoptotic cell death in the COLO 205 cells.
4. Discussion
The present study was to investigate the cytotoxic eﬀects
against human COLO 205 colon cancer cells and anti-
cancer mechanisms of 10 4,7-dimethoxy-1,3-benzodioxole
derivatives of SY-1 isolated from dried fruiting bodies of
A. camphorata (Table 1). Our previous study is the ﬁrst
demonstration that SY-1 inhibits human colon cancer cell
proliferation through arrest of the cell cycle and activation
of the cellular apoptosis response [4]. However, other
derivatives with the structural skeleton of 5-substituted 4,7-
dimethoxy-1,3-benzodioxoleswerestillnotfoundanticancer
activities yet. Thus, we tried to study anti-proliferative
eﬀects on COLO 205 colon cancer cell of the 5-substituted
derivatives varied with cyano (−CN), carboxylic (−COOH),
2-hydroxyethyl (−CH2CH2OH), methyl ester (−COOCH3),
propyl (−CH2CH2CH3), 2-propen-1-yl (−CH2CH = CH2)
and three aromatic side chain groups. Structure–activity
relationships among the 10 5-substituted 4,7-dimethoxy-
1,3-benzodioxole compounds derived from SY-1 (Figure 1)
showed that apiole is the most potent compound against
COLO 205 cells. However if the modiﬁcation on 5-positionEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Schematic diagram of signaling pathways involved in apiole-induced cell-cycle arrest and apoptosis in human COLO 205 cells.
is substituted with an n-propyl (compound 5), other than
allyl(apiole),compound5showsveryweakanti-proliferative
activity on COLO 205 cells. In 1984 Phillips et al. discovered
that apiole have only very low adduct-forming ability in
vivo [19]. Moreover, apiole is phytotoxic to the monocots
and are weakly antifungal and is not toxic to the MIB-
producing cyanobacterium O. perornata and the green alga
S. capricornutum [20]. To our knowledge, our study in the
article is the ﬁrst ﬁnding that apiole has anti-proliferation
eﬀect via G0/G1 phase in COLO 205 cells.
Apiole showed the most eﬃcient suppression of COLO
205 cell proliferation and excitedly was less cytotoxic to nor-
mal colonic FHC cells (Figure 1). p53 is a tumor suppressor
protein that has been correlated with cell cycle arrest [21].
Cell cycle progression is regulated by proteins downstream
of p53, including p21, p27 (CDKi) and cyclin D1 [22–24].
A recent study demonstrated that knockdown of mutant
p53 enhances the sensitivity of human colon tumor cells to
the growth suppression caused by various chemotherapeutic
drugs[25].Inthepreviousstudy,SY-1inhibitedcoloncancer
cell growth in the G0/G1 phase and induced apoptosis and
colonyformationinCOLO205cells(wild-typep53),butnot
in HT 29 (mutant p53) cells [4]. Apiole is an SY-1 analogue,
and the present study showed that it can inhibit the growth
of COLO 205 cells more profoundly than SY-1 treatment. By
ﬂow cytometry analysis, apiole at a concentration of 75μM
was found to induce G0/G1 cell cycle arrest of COLO 205
cells (Figure 2(a)). With regard to related cell cycle proteins,
our data demonstrate that p53 and its regulatory gene, p21
and p27, were transcriptionally upregulated, which in turn
mediated apiole-induced G0/G1 arrest in COLO 205 cells by
inhibiting cyclin D1 (Figure 2(b)).
The recent study further demonstrated that the cytosolic
p53 directly activated the proapoptotic bax protein [26].
Our study demonstrated that apiole induced p53 and bax
protein expression Figure 5. Based on these ﬁndings, we
propose that when p53 accumulates in the cytosol, it can
function analogously to the subset of proapoptotic bcl-2
protein to activate bax and trigger the apoptosis mediated
by mitochondria-signaling processes. In the study, cleavage
of caspase 8 was detected in COLO 205 cells in response to a
lower dose (75μM) of apiole. In contrast, proapoptotic bax,
bcl-2 proteins and cleavage of caspase 9 were detected only
at a higher dose (>150μM). The sub-G1-phase population
of COLO 205 cells was only detected 36 hours after apiole
(>150μM) treatment (Figures 3(a)–3(d)). The extrinsic
caspase 8 pathway and the intrinsic mitochondrial pathway
are the two major signaling pathways that regulate apoptosis.
Activation of bid protein by caspase 8 links the extrinsic
and intrinsic apoptotic pathways through mitochondrial
damage [27]. Our data show that apiole-induced apoptosis
in COLO 205 cells occurred via the mitochondrial (caspase
9) pathway and the caspase 8 pathway, with the possible
link of bid protein activity between the two pathways. A
molecular marker for apoptosis, cleaved caspase 3, increased
immediately prior to COLO 205 cell death. In conclusion,
apiole appears to be a universal inhibitor of cancer cell
proliferation via induction of G0/G1 phase cell cycle arrest
and apoptosis through activation of p53 signaling in the
COLO 205 human colon cancer cell line. These observations
suggest that apiole could be used as a novel treatment in
cancer chemotherapy.
Funding
National Science Council of R.O.C. (grant NSC 96-2320-
B-040-010 to Y.-Y. L.). Chung Shan Medical University,
Taichung, Taiwan (grant CSMU 94-OM-B-006 to Y.-Y. L.)8 Evidence-Based Complementary and Alternative Medicine
Acknowledgment
Hsiu-Man Lien and Po-Tsun Kuo contributed equally to this
work.
References
[1] T. R. Asmis and L. Saltz, “Systemic therapy for colon cancer,”
Gastroenterology Clinics of North America,v o l .3 7 ,n o .1 ,p p .
287–295, 2008.
[2] R. Durai, S. Y. Yang, A. M. Seifalian, and M. C. Winslet,
“Principles and applications of gene therapy in colon cancer,”
Journal of Gastrointestinal and Liver Diseases,v o l .1 7 ,n o .1 ,p p .
59–67, 2008.
[3] T. Kuwai, T. Nakamura, T. Sasaki et al., “Targeting the EGFR,
VEGFR, and PDGFR on colon cancer cells and stromal cells
is required for therapy,” Clinical and Experimental Metastasis,
vol. 25, no. 4, pp. 477–489, 2008.
[4] H. M. Lien, H. W. Lin, Y. J. Wang et al., “Inhibition
of anchorage-independent proliferation and G0/G1 cell-
cycle regulation in human colorectal carcinoma cells by
4,7-dimethoxy-5-methyl-1,3-benzodioxole isolated from the
fruiting body of Antrodia camphorate,” Evidence-Based Com-
plementary and Alternative Medicine, 2009.
[5] K. Neuhaus-Carlisle, W. Vierling, and H. Wagner, “Calcium-
channel blocking activity of essential oils from Petroselinum
crisp., Api graveolens and isolated phenylpropane con-
stituents,” Pharmaceutical and Pharmacological Letters, vol. 3,
pp. 77–79, 1993.
[6] A. A. Shahat, G. El-Barouty, R. A. Hassan, F. M. Hammouda,
F.H.Abdel-Rahman,andM.A.Saleh,“Chemicalcomposition
and antimicrobial activities of the essential oil from the seeds
of Enterolobium contortisiliquum (leguminosae),” Journal of
Environmental Science and Health B, vol. 43, no. 6, pp. 519–
525, 2008.
[ 7 ]A .A .A l ia n dM .T .I b r a h i m ,“ B e h a v i o r a le ﬀects of essential
o i lf r o mS a l v i aa e g y p t i a c ai nr a t s , ”Mansoura Journal of
Pharmaceutical Sciences, vol. 23, pp. 72–86, 2007.
[8] J. Begum, M. Yusuf, J. U. Chowdhury et al., “Composition and
antifungal activity of essential oil of leaves of Cinnamomum
verum Presl. grown in Bangladesh,” Indian Perfumer, vol. 51,
pp. 15–18, 2007.
[9] N. I. Bhuiyan, J. U. Chowdhury, J. Begum, and M. A. Azim,
“Constituents of the essential oils from Caraway (Carum carvi
L.) leaves and fruits,” Dhaka University Journal of Science, vol.
56, pp. 247–249, 2008.
[ 1 0 ]M .D a h i a ,H .L a o u e r ,A .N .C h a k e r ,S .P r a d o ,U .J .M e i e r h e n -
rich, and N. Baldovini, “Chemical composition and antibac-
terial activity of Pituranthos chloranthus volatile oil,” Natural
Product Communications, vol. 2, pp. 1159–1162, 2007.
[11] K. Neuhaus-Carlisle, W. Vierling, and H. Wagner, “Screening
of plant extracts and plant constituents for calcium-channel
blocking activity,” Phytomedicine, vol. 4, no. 1, pp. 67–69,
1997.
[12] K. M. Siddiqui and D. P. Chopra, “Primary and long term
epithelial cell cultures from human fetal normal colonic
mucosa,” In Vitro, vol. 20, no. 11, pp. 859–868, 1984.
[13] H. Lin, M.-C. Chen, C.-Y. Chiu, Y.-M. Song, and S.-Y.
Lin, “Cdk5 regulates STAT3 activation and cell proliferation
in medullary thyroid carcinoma cells,” Journal of Biological
Chemistry, vol. 282, no. 5, pp. 2776–2784, 2007.
[14] Y.-S. Ho, Y.-J. Wang, and J.-K. Lin, “Induction of p53
and p21/WAF1/CIP1 expression by nitric oxide and their
association with apoptosis in human cancer cells,” Molecular
Carcinogenesis, vol. 16, no. 1, pp. 20–31, 1996.
[15] Y.-S. Ho, C.-H. Wu, H.-M. Chou et al., “Molecular mecha-
nisms of econazole-induced toxicity on human colon cancer
cells: G0/G1 cell cycle arrest and caspase 8-independent
apoptotic signaling pathways,” Food and Chemical Toxicology,
vol. 43, no. 10, pp. 1483–1495, 2005.
[16] C. H. Wu, J. H. Jeng, Y. J. Wang et al., “Antitumor eﬀects of
miconazole on human colon carcinoma xenografts in nude
mice through induction of apoptosis and G0/G1 cell cycle
arrest,” Toxicology and Applied Pharmacology, vol. 180, pp. 22–
35, 2002.
[17] N. A. Thornberry and Y. Lazebnik, “Caspases: enemies
within,” Science, vol. 281, no. 5381, pp. 1312–1316, 1998.
[ 1 8 ]W .S .E l - D e i r y ,T .T o k i n o ,V .E .V e l c u l e s c ue ta l . ,“ W A F 1 ,a
potential mediator of p53 tumor suppression,” Cell, vol. 75,
no. 4, pp. 817–825, 1993.
[19] D. H. Phillips, M. V. Reddy, and K. Randerath, “32P-post-
labelling analysis of DNA adducts formed in the livers of
animals treated with safrole, estragole and other naturally-
occurring alkenylbenzenes: II Newborn male B6C3F1 mice,”
Carcinogenesis, vol. 5, pp. 1623–1628, 1984.
[20] K. M. Meepagala, G. Sturtz, D. E. Wedge, K. K. Schrader,
and S. O. Duke, “Phytotoxic and antifungal compounds from
two Apiaceae species, Lomatiumcalifornicum andLigusticum
hultenii, rich sources of Z-ligustilide and apiol, respectively,”
Journal of Chemical Ecology, vol. 31, no. 7, pp. 1567–1578,
2005.
[21] S. Jin and A. J. Levine, “The p53 functional circuit,” Journal of
Cell Science, vol. 114, no. 23, pp. 4139–4140, 2001.
[22] T. Hunter and J. Pines, “Cyclins and cancer II: cyclin D and
CDK inhibitors come of age,” Cell, vol. 79, no. 4, pp. 573–582,
1994.
[23] D. O. Morgan, “Principles of CDK regulation,” Nature, vol.
374, no. 6518, pp. 131–134, 1995.
[24] C. J. Sherr and J. M. Roberts, “Inhibitors of mammalian G1
cyclin-dependent kinases,” Genes and Development, vol. 9, no.
10, pp. 1149–1163, 1995.
[25] W. Yan, G. Liu, A. Scoumanne, and X. Chen, “Suppression
of inhibitor of diﬀerentiation 2, a target of mutant p53, is
required for gain-of-function mutations,” Cancer Research,
vol. 68, no. 16, pp. 6789–6796, 2008.
[26] J. E. Chipuk, T. Kuwana, L. Bouchier-Hayes et al., “Direct
activation of bax by p53 mediates mitochondrial membrane
permeabilization and apoptosis,” Science, vol. 303, no. 5660,
pp. 1010–1014, 2004.
[27] H. Li, H. Zhu, C.-J. Xu, and J. Yuan, “Cleavage of BID by
caspase 8 mediates the mitochondrial damage in the Fas
pathway of apoptosis,” Cell, vol. 94, no. 4, pp. 491–501, 1998.